News
Oncopathology or cancer pathology is a specialised branch of pathology focused on diagnosing and characterising tumours ...
Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that could pave the way for a new generation of immunotherapies. Cancer ...
Cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to ...
18d
News-Medical.Net on MSNBreakthrough study reveals killing power of CD4 T cells against cancerIn the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...
UofL Health – Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA approved assay for solid tumor testing. The test, known as ...
5d
Study Finds on MSNWhy Turtles Might Hold Secrets To Extraordinary Cancer ResistanceTurtles live centuries with almost no cancer. Here’s what researchers found inside their ancient cells — and why it matters ...
Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA ...
A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer ...
The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.
Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma (ChRCC) and those that are present are indifferent to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results